Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko bought 32,500 shares of the company’s stock in a transaction on Monday, October 10th. The stock was purchased at an average price of $0.43 per share, with a total value of $13,975.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Repro-Med Systems, Inc. (NASDAQ:REPR) traded down 2.33% during midday trading on Tuesday, hitting $0.42. The stock had a trading volume of 14,500 shares. Repro-Med Systems, Inc. has a 1-year low of $0.28 and a 1-year high of $0.59. The stock has a market cap of $15.95 million and a price-to-earnings ratio of 84.00. The firm’s 50-day moving average price is $0.41 and its 200-day moving average price is $0.39.

Insider Buying and Selling by Quarter for Repro-Med Systems (NASDAQ:REPR)

Repro-Med Systems Company Profile

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

5 Day Chart for NASDAQ:REPR

Receive News & Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related companies with's FREE daily email newsletter.